Torrent Pharmaceuticals reported a 21.9% year-on-year decline in Q4 consolidated net profit to ₹389 crore, while revenue rose ...

Torrent Pharma posted strong Q4 revenue growth led by its India business and rapid gains in the semaglutide market segment.

This article first appeared on GuruFocus. Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) is set to release its Q4 2026 earnings on May 22, 2026. The consensus estimate for Q4 2026 revenue is $40.16 ...

Torrent Pharma's Q4 profit dropped 22% as JB Pharma integration costs pushed up expenses, despite strong growth in ...

The Torrent dropped their season finale to Montreal 2-1 in a shootout and lost the right to the first-overall pick in the ...

A JB Chemicals factory in Gujarat in western India. Torrent Pharmaceuticals—controlled by India billionaire brothers Sudhir and Samir Mehta—has agreed to buy U.S. private equity giant KKR’s stake in ...

Torrent’s semaglutide launches and the addition of JB Pharma are expanding the company’s presence in chronic therapies, ...

It’s not exactly a secret that torrent apps don’t have the best reputation. Why? Well, they’re often used to share illegal content, mainly movies, TV shows, and music. Well, there’s a reason why ...